Cancer Biopsy Market Analysis

Cancer Type (Breast, Colorectal, Stomach, Lung, Liver, Prostrate, Ovarian, And Other Cancer Types)

In cancer type, the breast cancer segment in the cancer biopsy market is projected to register the highest share of 21.1% by the end of 2037. According to the American Cancer Society, 310,720 new cases of invasive breast cancer are projected to be diagnosed in women in 2024, causing as many as 42,250 deaths, among women. It further predicts that nearly 2,790 men will also be diagnosed with breast cancer by the end of 2024, registering approximately 530 deaths from the disease. Owing to the rising amount of breast cancers especially among women, the segment is anticipated to garner the highest growth rate in the upcoming years, in the cancer biopsy market.

End user (Hospitals, Cancer Research Centers, Diagnostic Centers, and Research and Academics)

Hospitals are projected to dominate the end user segment primarily due to their comprehensive healthcare services and advanced diagnostic capabilities. The hospitals are equipped with state-of-the-art imaging and laboratory facilities, facilitating a wide range of biopsy procedures, including surgical and minimally invasive techniques. The increasing number of cancer cases and the need for timely diagnosis and treatment further strengthen hospital’s positions as primary providers of biopsy services. As healthcare continues to evolve, hospitals are likely to remain at the forefront of the cancer biopsy market.

Our in-depth analysis of the cancer biopsy market includes the following segments:

Biopsy Type	Tissue biopsy Needle biopsy Surgical biopsy Other tissue biopsy types Liquid biopsy Circulating tumor cells (CTCs) Circulating tumor DNA (ctDNA) Other liquid biopsy types Image-guided biopsy Other biopsy types
Products & Services	Products Biopsy needles/guns Fine needle aspiration (FNA) Core needle biopsy (CNB) Vacuum-assisted biopsy devices Biopsy forceps General biopsy forceps Hot biopsy forceps Kits and reagents Consumables Services
Cancer Type	Breast cancer Colorectal cancer Stomach cancer Lung cancer Liver cancer Prostate cancer Ovarian cancer Other cancer types
End user	Hospitals Cancer research centers Diagnostic centers Research and academics

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the cancer biopsy market was over USD 23.5 billion.

The market size for the cancer biopsy market is projected to reach USD 63.9 billion by the end of 2037 expanding at a CAGR of 8.7% during the forecast period i.e., between 2025-2037.

The major players in the market are BD (Becton, Dickinson and Company), Biodesix (Integrated Diagnostics), Chronix Biomedical, Inc. (Oncocyte Corporation), and others.

In terms of cancer type segment, the breast cancer segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 42.7% by the end of 2037 and provide more business opportunities in the future.

Cancer Biopsy Market Analysis